STAT3 and melanoma: Bhandarkar and colleagues demonstrated that Tris DBA can reduce melanoma cell proliferation by inhibiting the activation of MAPK, Akt, STAT3, and phospho-S6 kinase, and downregulated the expression of N-myristoyltransferase-1 [36].